Companies in #Biopharmaceuticals
Found 14 companies operating in this sector.
Biopharmaceutical company. See source for details.
Biopharmaceutical company. See source for details.
Neurotechnology company based in Baltimore developing NeuroPASS platform for direct-to-brain therapeutic delivery, bypassing the blood-brain barrier to treat neurological diseases. First fully implantable platform for long-term, programmable drug delivery. Closed $20M Series B.
Medical device company developing cardiovascular embolic protection devices for transcatheter and surgical cardiac procedures. Raised $81.9M in funding
Clinical-stage oncology company developing precision medicines targeting menin inhibition and farnesyl transferase for acute leukemias and head/neck cancer. Lead candidates ziftomenib (menin inhibitor) and tipifarnib (FTI) address genetically defined patient populations with high unmet need.
Optogenetic gene therapy for vision restoration using proprietary Multi-Characteristic Opsin (MCO) platform. MCO-010 is first broad-spectrum, ambient light-activated optogenetic therapy — disease-agnostic, demonstrated vision restoration in clinical trials. Targeting Retinitis Pigmentosa, Stargar...
Clinical-stage biotechnology developing brain-penetrant NLRP3 inflammasome inhibitors for the treatment of chronic inflammatory diseases
Late-stage clinical biopharma developing oral small-molecule bradykinin B2 receptor antagonists (PHA121) for bradykinin-mediated diseases, led by hereditary angioedema (HAE) program; Nasdaq-listed (PHVS) with offices in Netherlands and Switzerland
Biopharmaceutical company. See source for details.
Clinical-stage regenerative medicine company developing islet cell replacement therapy for insulin-dependent (Type 1) diabetes. Lead pipeline asset is a stem-cell-derived islet cell therapy designed to eliminate or significantly reduce the need for daily insulin injections. Pipeline also includes...